Zdrowie i gospodarka · 23/02/2023

Patient-Focused Drug Development for Long COVID; Public Meeting; Request for Comments

The Food and Drug Administration (FDA) is hosting a public meeting to gather patient perspectives on Long COVID, treatment approaches, and treatment decision factors. The meeting aims to inform FDA's patient-focused drug development efforts for Long COVID.